ArticleEmerging infectious diseases2008
Invasive bacterial diseases in northern Canada.
Article in Emerging infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Prevalence ofInternational journal of circumpolar health · 2024Article
- Regional differences in pediatric pneumococcal vaccine schedules for Indigenous children in Canada: an environmental scan.BMC health services research · 2024Article
- Carriage ofJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024Article
- Invasive bacterial diseases in northern Canada, 1999 to 2018.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021Article
- Burden of respiratory infections and otitis media in the Inuit population of Nunavik, Quebec, Canada.International journal of circumpolar health · 2020Article
- Limited impact of pneumococcal vaccines on invasive pneumococcal disease in Nunavik (Quebec).Canadian journal of public health = Revue canadienne de sante publique · 2019Article
- Epidemiology of invasive pneumococcal disease in indigenous and non-indigenous adults in northwestern Ontario, Canada, 2006-2015.BMC infectious diseases · 2018Observational
- Invasive Bacterial Diseases in Northern Canada, 2006-2013.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2016Article
- Population-based epidemiology and microbiology of community-onset bloodstream infections.Clinical microbiology reviews · 2014Review
- Uptake of pneumococcal vaccines in the Nordic region of Nunavik, province of Quebec, Canada.Canadian journal of public health = Revue canadienne de sante publique · 2014Article
- Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010.International journal of circumpolar health · 2014Article
- Indigenous populations health protection: a Canadian perspective.BMC public health · 2012Article
- Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.BMC infectious diseases · 2012Article
- The International Polar Year, 2007-2008, an opportunity to focus on infectious diseases in Arctic regions.Emerging infectious diseases · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
International Circumpolar Surveillance (ICS) is a population-based invasive bacterial disease surveillance network. Participating Canadian regions include Yukon, Northwest Territories, Nunavut, and northern regions of Québec and Labrador (total population 132,956, 59% aboriginal). Clinical and demographic information were collected by using standardized surveillance forms. Bacterial isolates were forwarded to reference laboratories for confirmation and serotyping. After pneumococcal conjugate vaccine introduction, crude annual incidence rates of invasive Streptococcus pneumoniae decreased from 34.0/100,000 population (1999-2002) to 23.6/100,000 population (2003-2005); substantial reductions were shown among aboriginals. However, incidence rates of S. pneumoniae, Haemophilus influenzae, and group A streptococci were higher in aboriginal populations than in non-aboriginal populations. H. influenzae type b was rare; 52% of all H. influenzae cases were caused by type a. Data collected by ICS contribute to the understanding of the epidemiology of invasive bacterial diseases among northern populations, which assists in formulation of prevention and control strategies, including immunization recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.